Sax Wealth Advisors, LLC Amgen Inc Transaction History

Sax Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $172,101 - $209,148	655 New	655 $204,000
Q1 2023 May 05, 2023	BUY	$225.79 - $275.2 $451 - $550	2 Added 0.17%	1,156 $279,000
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $75,808 - $96,324	-331 Reduced 22.29%	1,154 $303,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $32,546 - $36,706	-145 Reduced 8.9%	1,485 $335,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $461 - $513	2 Added 0.12%	1,630 $396,000
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.06%	1,628 $394,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $323,577 - $370,305	1,627 New	1,627 $366,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sax Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sax Wealth Advisors, LLC with notifications on news.